Abstract
Background In 2017, three brick and mortar supervised consumption sites (SCS) began operating in Montreal, Canada. Opponents argued the sites would attract people who use drugs to the respective neighbourhoods, contributing to reductions in residential real estate values.
Methods We used controlled interrupted time series and hedonic price models to evaluate the effects of Montreal’s SCSs on residential real estate. We linked the Quebec Professional Association of Real Estate Brokers’ housing sales data provided by Centris Inc. with Statistics Canada’s census tract data, neighbourhood proximity measures, and Canadian Urban Environmental Health Research Consortium’s gentrification measures. We restricted analysis to sales between 1 January 2014 and 31 December 2021, and within 1,000m of a SCS (treated) or a men’s homeless shelter (control). We controlled for internal (e.g., number of bed/bathrooms, unit size) and external attributes (e.g., neighbourhood demographics; proximity to amenities), and included a spatio-temporal lag to account for correlation between sales.
Results When controlling for census tract data and gentrification measures, the price of homes sold immediately after SCSs were implemented was 5.2% lower (95% CI: -1.4%, -8.8%) compared with control sales (level effect). However, the monthly value increased 0.6% faster (95% CI: 0.4%, 0.7%) in treated neighbourhoods (trend effect). Compared with the counterfactual (i.e., SCS never implemented), sales in treated neighbourhoods observed an absolute increase of $37,931.86 (95% CI: $12,223.35, $138,088.50) by December 2021. When we also controlled for proximity scores, the immediate level effect post-implementation disappeared (−3.3%, 95% CI: -0.7%, 1.1%), but monthly trend gains persisted (0.9%, 95% CI: 0.7%, 1.0%).
Conclusion We observed a modest negative effect on prices immediately following SCS implementation. However, controlling for proximity to neighbourhood amenities eliminated the level effect. Positive month-on-month price gains were consistently observed, suggesting community wide benefits of SCS implementation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by an Insights Development Grant from the Social Sciences and Humanities Research Council of Canada (Grant # 430 2022 00061) to DP. DP is also supported by a Junior 1 Scientist Award from the fonds de recherche du Quebec Sante (Award #297427). The funders of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Declaration of interests We declare no competing interests.
Data sharing Due to commercial restrictions, supporting data is not available.
Funding This study was supported by an Insights Development Grant from the Social Sciences and Humanities Research Council of Canada (Grant # 430-2022-00061) to DP. DP is also supported by a Junior 1 Scientist Award from the fonds de recherche du Québec – Santé (Award #297427). The funders of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.
Data Availability
Due to commercial restrictions, supporting data is not available.